This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Sue Washer, MBA
President and CEO at Applied Genetic Technologies Corporation (AGTC)


Sue Washer, President and founding CEO of Applied Genetic Technologies Corporation (AGTC), has 35 years of impressive career accomplishments, including diverse experience in the pharmaceutical/biologics industry, research and development, and community and industry association leadership.

Sue has transformed AGTC from a small academic spin-out to a leader in the gene therapy field with five products in active development for the treatment of rare inherited retinal diseases. During her tenure, Sue secured investments of over $91M for AGTC, negotiated and closed on a major collaboration with a top five Biotech company, and led AGTC in efficiently completing critical scientific milestones.

An experienced entrepreneur with a strong scientific and operational background, Sue brings a decade of experience in pharmaceutical management and research with Abbott Labs and Eli Lilly & Company and more than 16 years of senior management experience with entrepreneurial firms, including three start-ups.

Sue currently serves on the board of directors of BIO, the Alliance for Regenerative Medicine (ARM) and Histogenics, a public company in the cell therapy space. She earned her undergraduate degree in biochemistry from Michigan State University and an MBA from the University of Florida where she graduated from the Warrington College of Business Entrepreneurship Program.

Sue Washer, MBA's Network

Agenda Sessions

  • Building Effective Partnerships to Advance New Drugs